Armistice Capital’s MediWound MDWD Stock Holding History

Armistice Capital’s Portfolio MDWD Stock Details MDWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-273,646	Closed	-$2.66M	–	217
2022 Q3	$2.66M	Buy	+273,646	New	+$3.45M	0.05%	118

Other funds holding MDWD

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

UIC

Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

SIG

Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

MIH

Meitav Investment House Bene-Beraq, Israel $9.12B AUM 42.07% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

EIM

Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

ACM

Altium Capital Management New York $42M AUM

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Armistice Capital's MDWD Position: Q4 2022 in Review

Armistice Capital sold out of MediWound (MDWD) in Q4 2022, closing a stake of 273,646 shares — an estimated $2.66M sold.

Armistice Capital first reported a position in MDWD in Q3 2022 and held it in 1 quarter. The position peaked at $2.66M in Q3 2022. 19 funds tracked by Wall St. Rank hold MDWD as of Q4 2022.

Armistice Capital reported no remaining MediWound position as of Q4 2022 after selling out during the quarter.
Armistice Capital sold 273,646 MediWound shares in Q4 2022, an estimated $2.66M.
Armistice Capital first reported a position in MediWound in Q3 2022 and held it in 1 quarter.
Armistice Capital's MediWound position peaked at $2.66M in Q3 2022.
19 funds tracked by Wall St. Rank held MediWound as of Q4 2022.

Based on Armistice Capital's 13F filing for Q4 2022, filed 14 Feb 2023.